Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

EOLS stock hub

Evolus, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EOLSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

418.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

EOLS

In the news

Latest news · EOLS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-15.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EOLS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001570562
Company name	Evolus, Inc.
Country	United States
Country code	US
Cusip	30052C107
Employees	350
Employees Change	16%
Employees Change Percent	4.79
Enterprise value	$533.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2018-02-08
Isin	US30052C1071
Last refreshed	2026-05-10
Market cap	$418.8M
Market cap category	Small-Cap
Price	$6.36
Price currency	USD
Rev Per Employee	862,260x
Sector	Healthcare
Sic	2834
Symbol	EOLS
Website	https://www.evolus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.37%
EV Sales Forward	1.54x
EV/Sales	1.77x
FCF yield	-9.58%
P/S ratio	1.39x
PS Forward	1.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-10.42%
EBITDA Margin	-7.67%
Gross margin	66.06%
Gross Profit	$199.3M
Gross Profit Growth	5.78%
Gross Profit Growth Q	4.81%
Gross Profit Growth3 Y	25.19%
Gross Profit Growth5 Y	38.37%
Net Income	$-43.4M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-14.1%
Profit Margin	-14.39%
Profit Per Employee	$-124,066
ROA	-9.06
Roa5y	-12.84
ROCE	-20.6
ROIC	-15.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-45.94%
Cagr3y	-9.21%
Cagr5y	-7%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	9.56x
Revenue Growth Q	6.74x
Revenue Growth Quarters	24x
Revenue Growth Years	6x
Revenue Growth3 Y	24.49x
Revenue Growth5 Y	38.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.39
Assets	$220.6M
Cash	$49.8M
Current Assets	$138.9M
Current Liabilities	$68M
Debt	$164.9M
Equity	$-28.8M
Interest Coverage	-1.63
Liabilities	$249.4M
Long Term Assets	$81.7M
Long Term Liabilities	$181.4M
Net Cash	$-115.1M
Net Cash By Market Cap	$-27.48
Tangible Book Value	$-96.7M
Tangible Book Value Per Share	$-1.47
WACC	10.74

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.04
Inventory Turnover	5.88
Net Working Capital	$23.7M
Quick ratio	1.5
Working Capital	$70.9M
Working Capital Turnover	$4.12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.53%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-45.92%
200-day SMA	6.07
3Y total return	-25.18%
50-day SMA	4.89
50-day SMA vs 200-day SMA	50under200
5Y total return	-30.42%
All Time High	39.5
All Time High Change	-83.9%
All Time High Date	2018-06-07
All Time Low	2.85
All Time Low Change	123.16%
All Time Low Date	2020-10-29
ATR	0.34
Beta	1.29
Beta1y	0.56
Beta2y	0.89
Ch YTD	-4.36
High	6.58
High52	11.42
High52 Date	2025-05-08
High52ch	-44.31%
Low	6.32
Low52	3.86
Low52 Date	2026-03-30
Low52ch	64.77%
Ma50ch	30.09%
Premarket Change Percent	0.55
Premarket Price	$6.43
Premarket Volume	270
Price vs 200-day SMA	4.83%
RSI	75.73
RSI Monthly	42.99
RSI Weekly	55.59
Sharpe ratio	-0.58x
Sortino ratio	-0.75
Total Return	-2.53%
Tr YTD	-4.36
Tr1m	55.88%
Tr1w	19.33%
Tr3m	41.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	4
Analyst Price Target Top	$16.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	72,277,736x
Earnings Revenue Estimate Growth	5.51x
Operating Income	$-31.4M
Operating margin	-10.42
Price target	$15.5
Price Target Change	$144
Price Target Change Top	$157

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,599,037%
Float Percent	76.83%
Net Borrowing	34,981,000
Shares Insiders	11.08%
Shares Institutions	66.84%
Shares Out	65,854,751
Shares Qo Q	-0.25%
Shares Yo Y	2.53%
Short Float	13.08%
Short Ratio	7.68
Short Shares	10.05

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-60M
Average Volume	997,610.75x
Bv Per Share	-0.44
CAPEX	$-3.5M
Ch1m	55.88
Ch1w	19.33
Ch1y	-45.92
Ch3m	41.33
Ch3y	-25.18
Ch5y	-30.42
Ch6m	-3.05
Change	-0.47%
Change From Open	0.47
Close	6.39
Days Gap	-0.94
Depreciation Amortization	8,289,000
Dollar Volume	5,373,748.4
Earnings Date	2026-05-04
Earnings Time	amc
EBIT	$-31.4M
EBITDA	$-23.2M
EPS	$-0.67
F Score	2
FCF	$-40.1M
FCF EV Yield	-7.51x
FCF Per Share	$-0.61
Financing CF	26,587,000
Fiscal Year End	December
Founded	2,012
Goodwill	21,208,000
Income Tax	$861,000
Investing CF	-8,282,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	5.68
Ma150ch	12.01%
Ma20	5.29
Ma20ch	20.18%
Net CF	-18,102,000
Next Earnings Date	2026-08-04
Open	6.33
Optionable	Yes
Position In Range	15.38
Post Close	6.36
Postmarket Change Percent	-0.79
Postmarket Price	$6.31
Ppne	12,125,000
Pre Close	6.39
Price Date	2026-05-08
Relative Volume	0.85x
Revenue	301,791,000x
SBC By Revenue	6.59x
Share Based Comp	19,886,000
Tax By Revenue	0.29x
Tr6m	-3.05%
Us State	California
Volume	844,929
Z Score	-1.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EOLS pay a dividend?

Capital-return profile for this ticker.

Performance

EOLS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EOLS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.8%

Float: +76.8% of shares outstanding

Insider ownership

+11.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

EOLS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

75.7

Above 70: short-term overbought

Price vs 200-day MA

+4.8%

50/200-day relationship not available

Beta (5Y)

1.29

More volatile than the market

Sharpe ratio

-0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EOLS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current EOLS stock rating?

Evolus, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full EOLS analysis?

The full report lives at /stocks/EOLS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for EOLS?

The latest report frames EOLS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the EOLS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.